探索细胞外囊泡作为脊椎间盘退行症的新型治疗剂:传递,应用和机制
Yuxin Jin1, Ouqiang Wu1, Zhihua Chen1
1Department of Orthopaedics, Key Laboratory of Orthopaedics of Zhejiang Province, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang, China.
Stem cell research & therapy
|May 1, 2025
概括
细胞外囊泡疗法显示,通过向关键疾病途径和增强组织修复,有望预防椎间盘退化. 这种方法提供了一种超越当前以症状为中心的治疗方法的新策略.
科学领域:
- 生物医学工程 生物医学工程
- 再生医学是一种再生医学.
- 分子生物学分子生物学
背景情况:
- 椎间盘退化 (IVDD) 是老年人群的主要健康问题,目前的治疗只能控制症状.
- 现有的治疗方法无法阻止或逆转IVDD的退行性进展.
- 了解IVDD的分子机制对于开发有效的干预措施至关重要.
研究的目的:
- 审查椎间盘退化的致病机制.
- 探索细胞外囊泡 (EV) 治疗作为IVDD预防和修复的新策略.
- 讨论EV载荷 (蛋白质,RNA,脂质) 在调节IVDD通路中的治疗潜力.
主要方法:
- 关于IVDD病变发生的综合文献综述.
- 对IVDD目前治疗限制的分析.
- 基于EV的治疗策略及其组件的评估.
- 对EVs的生物工程修改和药物输送的审查.
主要成果:
- IVDD涉及复杂的途径,包括炎症,亡,烧亡,铁亡和自失调.
- 细胞外囊泡由于其载荷具有治疗潜力,可以调节这些退行性途径.
- 电动汽车在组织修复方面具有优势,可以通过生物工程和药物加载来增强.
结论:
- 细胞外囊泡疗法代表了对椎间盘退化有前途的预防策略.
- 电动汽车货物在变性磁盘内的修复机制中发挥着重要作用.
- 对EV治疗的进一步研究,包括克服当前的挑战,对于治疗IVDD的临床应用至关重要.
相关概念视频
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Intralumenal Vesicles and Multivesicular Bodies
3.3K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
3.3K


